2.57 USD
↗ 0.01 (0.39%)LIVE (AS OF 10:20 AM EDT)
Protara Therapeutics, Inc. Common Stock
TARANASDAQ • USD
Market: OPEN
Protara Therapeutics, Inc. Common Stock (TARA) is currently trading at $2.57. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Oct 6, 2026.
Open?$2.54
High?$2.57
Low?$2.52
Prev. Close?$2.56
Volume?61.6K
Avg. Volume?1.3M
VWAP?$2.54
Rel. Volume?0.05x
Bid / Ask
Bid?$2.56 × 400
Ask?$2.57 × 1.1K
Spread?$0.01
Midpoint?$2.57
Valuation & Ratios
Market Cap?151.3M
Shares Out?59.1M
Float?54.8M
Float %?92.7%
P/E Ratio?N/A
P/B Ratio?0.94
EPS?-$1.18
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
Themes
Employees
51
Market Cap
151.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2020-01-10
Address
345 PARK AVENUE SOUTH
NEW YORK, NY 10010
Phone: 646-844-0337
NEW YORK, NY 10010
Phone: 646-844-0337
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?68
Momentum?50
Short Sent.?48
Piotroski F-Score?0/9Weak
Altman Z-Score?2.89Grey
Confidence?49%Low
Short InterestVery High
Short % of Float?8.07%Elevated
Short Interest?4.4M
Days to Cover?10.3
Free Float54.8M
Avg Daily Volume427.2K
Settlement Date2026-09-15
Financial Health
Current Ratio?10.97Strong
Quick Ratio?10.97Strong
Cash Ratio?1.28Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.94CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-43.4%WEAK▾
S&P3
ROA?-39.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-66494000
Enterprise Value?$134.2M
Fundamentals ratios updated end of day